Elevated procalcitonin and C-reactive protein as potential biomarkers of sepsis in a subpopulation of thrombotic microangiopathy patients

Journal of Clinical Apheresis

Volumn 24, Issue 4, 2009, Pages 150-154

  Erickson, Yasuko O ^a   Samia, Noelle I ^b   Bedell, Bruce ^a   Friedman, Kenneth D ^c   Atkinson, Bonnie S ^c   Raife, Thomas J ^a  

^a UNIVERSITY OF IOWA   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c BLOOD RESEARCH INSTITUTE   (United States)

Author keywords

ADAMTS13; C reactive protein (CRP); Procalcitonin (PCT); Sepsis; Thrombotic microangiopathy (TMA)

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; PROCALCITONIN; VON WILLEBRAND FACTOR CLEAVING PROTEINASE;

ARTICLE; CONTROLLED STUDY; DISEASE MARKER; DISEASE SEVERITY; ENZYME ACTIVITY; ENZYME DEFICIENCY; HUMAN; MAJOR CLINICAL STUDY; PLASMAPHERESIS; PROTEIN BLOOD LEVEL; RETROSPECTIVE STUDY; SEPSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA; VON WILLEBRAND FACTOR CLEAVING PROTEINASE DEFICIENCY;

ADAM PROTEINS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CALCITONIN; HEMOLYTIC-UREMIC SYNDROME; HUMANS; PROTEIN PRECURSORS; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RETROSPECTIVE STUDIES; SEPSIS;

EID: 69249138711     PISSN: 07332459     EISSN: 10981101     Source Type: Journal    
DOI: 10.1002/jca.20205     Document Type: Article

References (28)

1. Sadler E. Von Willebrand factor, ADAMTS13, and thrombotic thrombocytopenic purpura. Blood 2008;112:11-18.
2. Meisner M. Procalcitonin (PCT). New York: Georg Thieme Verlag; 2000. 196 pp.
3. Meisner M. Pathobiochemistry and clinical use of procalcitonin. Clin Chim Acta 2002;323:17-29.
4. Reinhart K, Karzai W, Meisner M. Procalcitonin as a marker of the systemic inflammatory response to infection. Intens Care Med 2000;26:1193-1200.
5. Black S, Kushner I, Samols D. C-reactive protein. J Biol Chem 2004;279:48487-48490.
6. Clyne B, Olshaker J. The C-reactive protein. J Emerg Med 1999;17:1019-1025.
7. Castelli G, Pognani C, Meisner M, Stuani A, Bellomi D, Sgarbi L. Procalcitonin and C-reactive protein during systemic inflammatory response syndrome, sepsis and organ dysfunction. Crit Care 2004;8:R234-R242.
8. Raife T, Atkinson B, Montgomery RR, Vesely S, Friedman KD. Severe deficiency of VWF-cleaving protease (ADAMTS13) activity defines a distinct population of thrombotic microangiopathy patients. Transfusion 2004;44:146-150.
9. Veyradier A, Obert B, Houllier A, Meyer D, Girma J-P. Specific von Willebrand factor-cleaving protease in thrombotic microangiopathies:a study of 111 cases. Blood 2001;98:1765-1772.
10. Vesely S, George J, Lämmle B, Studt J-D, Alberio L, El-Harake M, Raskob G. ADAMTS13 activity in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: relation to presenting features and clinical outcomes in a prospective cohort of 142 patients. Blood 2003;102:60-68.
11. Moore J, Hayward C, Warkentin T, Kelton J. Decreased von Willebrand factor protease activity associated with thrombocytopenic disorders. Blood 2001;98:1842-1846.
12. Raife T, Lentz S, Atkinson B, Vesely S, Hessner M. Factor V Leiden: a genetic risk factor for thrombotic microangiopathy in patients with normal von Willebrand factor-cleaving protease activity. Blood 2002;99:437-442.
13. Raife TJ, Atkinson BS, Aster RH, McFarland JG, Gottschall JL. Minimal evidence of platelet and endothelial cell reactive antibodies in thrombotic thrombocytopenic purpura. Am J Hematol 1999;62:82-87.
14. O'Grady N, Barie P, Bartlett J, Bleck T, Carroll K, Kalil A, Linden P, Maki D, Nierman D, Pasculle W, Masur H. Guidelines for evaluation of new fever in critically ill adult patients: 2008 update from the American College of Critical Care Medicine and the Infectious Disease Society of America. Crit Care Med 2008;36:1330-1349.
15. Helsel DR. Nondetects and Data Analysis: Statistics for Censored Environmental Data. New York: Wiley; 2005.
16. Sierra R. C-reactive protein and procalcitonin as markers of infection, inflammatory response, and sepsis. Clin Pulm Med 2007;14:127-139.
17. Dorizzi RM, Polati E, Sette P, Ferrari A, Rizzotti P, Luzzani A. Procalcitonin in the diagnosis of inflammation in intensive care units. Clin Biochem 2006;39:1138-1143.
18. Uzzan B, Cohen R, Nicolas P, Cucherat M, Perret G. Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis. Crit Care Med 2006;34:1996-2003.
19. Rintala E, Aittoniemi J, Laine S, Nevalainen J, Nikoskelainen J. Early identification of bacteremia by markers of systemic inflammation. Scand J Clin Lab Invest 2001;61:523-530.
20. Claeys R, Vinken S, Spapen H, ver Elst K, Decochez K, Huyghens L, Gorus F. Plasma procalcitonin and C-reactive protein in acute septic shock: clinical and biological correlates. Crit Care Med 2002;30:757-762.
21. Remuzzi G. HUS and TTP: variable expression of a singe entity. Kidney Int 1987;32:292-308.
22. Vesely SK, George J, Atkinson B, Raife TJ. Thrombotic thrombocytopenic purpura (TTP) versus hemolytic-uremic syndrome (HUS) in adults: analysis of clinical features and outcomes. Blood 2000;96:630a.
23. Laurence J, Mitra D, Steiner M, Staiano-Coico L, Jaffe E. Plasma from patients with idiopathic and human immunodeficiency virus-associated thrombotic thrombocytopenic purpura induces apoptosis in microvascular endothelial cells. Blood 1996;87:3245-3254.
24. Mitra D, Jaffe E, Weksler B, Hajjar K, Soderland C, Laurence J. Thrombotic thrombocytopenic purpura and sporadic hemolytic-uremic syndrome plasmas induce apoptosis in restricted lineages of human microvascular endothelial cells. Blood 1997; 89:1224-1234.
25. Shariatmadar S, Nassiri M, Vincek V. Effect of plasma exchange on cytokines measured by multianalyte bead array in thrombotic thrombocytopenic purpura. Am J Hematol 2005; 79:83-88.
26. Bernardo A, Ball C, Nolasco L, Moake J, Dong J. Effects of inflammatory cytokines on the release and cleavage of the endothelial cell-derived ultralarge von Willebrand factor multimers under flow. Blood 2004;104:100-106.
27. Dong J, Moake J, Nolasco L, Bernardo A, Arceneaux W, Shrimpton C, Schade A, McIntire L, Fujikawa K, Lopez J. ADAMTS-13 rapidly cleaves newly secreted ultralarge von Willebrand factor multimers on the endothelial surface under flowing conditions. Blood 2002;100:4033-4039.
28. Motto DG, Chauhan AK, Zhu G, Homeister J, Lamb CB, Desch KC, Zhang W, Tsai H-M, Wagner DD, Ginsburg D. Shigatoxin triggers thrombotic thrombocytopenic purpura in genetically susceptible ADAMTS13-deficient mice. J Clin Invest 2005; 115:2752-2761.